EPIX Pharmaceuticals, Inc. 4

Accession 0001209191-08-005417

CIK 0001027702operating

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 5:34 PM ET

Size

31.1 KB

Accession

0001209191-08-005417

Insider Transaction Report

Form 4

Period: 2008-01-23

EPIX Pharmaceuticals, Inc.EPIX

Kauffman Michael G

DirectorChief Executive Officer

Transactions

Other
Common Stock
2008-01-23−60,025→ 169,127 total
Other
Stock Option (Right to Buy)
2008-01-23−3,363→ 11,583 total
Exercise: $2.18Exp: 2013-08-11→ Common Stock (3,363 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−2,158→ 42,442 total
Exercise: $1.74Exp: 2015-04-28→ Common Stock (2,158 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−5,946→ 13,874 total
Exercise: $2.18Exp: 2013-08-11→ Common Stock (5,946 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−2,583→ 8,897 total
Exercise: $2.18Exp: 2014-01-29→ Common Stock (2,583 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−15,213→ 122,880 total
Exercise: $0.98Exp: 2015-01-18→ Common Stock (15,213 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−25,438→ 59,356 total
Exercise: $0.98Exp: 2014-09-23→ Common Stock (25,438 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−21,487→ 50,135 total
Exercise: $0.98Exp: 2015-01-18→ Common Stock (21,487 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−7,337→ 17,120 total
Exercise: $1.74Exp: 2015-04-28→ Common Stock (7,337 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−8,438→ 141,562 total
Exercise: $7.20Exp: 2016-08-18→ Common Stock (8,438 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−1,106→ 54,207 total
Exercise: $6.50Exp: 2017-02-05→ Common Stock (1,106 underlying)
Other
Stock Option (Right to Buy)
2008-01-23−1,033→ 3,559 total
Exercise: $2.18Exp: 2014-04-29→ Common Stock (1,033 underlying)

Footnotes (8)

[F1]Pursuant to a divorce decree, the reporting person transferred to his ex-wife 60,025 shares of EPIX common stock and vested employee stock options to purchase 94,102 shares of EPIX common stock. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife.
[F2]Option becomes exercisable in 16 equal quarterly installments, with the first quarterly vesting occurring on November 18, 2006, and with 6.25% of the option becoming exercisable on the first day of each subsequent three month period thereafter until fully exercisable.
[F3]The option vests over a 3.75-year period at a rate of 6.667% per quarter, with the first quarterly vesting occurring on May 5, 2007.
[F4]The option is fully vested.
[F5]The option vests over a four year period at a rate of 25% on January 29, 2005, and the balance vesting in equal annual installments over the remaining three years.
[F6]The option becomes exercisable in 16 equal quarterly installments at a rate of 6.25% per quarter, with the first quarterly vesting occurring on July 29, 2004.
[F7]The option began vesting as to 1/11th of 2,557 of the shares each month beginning on February 18, 2005, approximately 1/12th of 26,308 of the shares each month beginning on January 18, 2006 and approximately 1/25th of 109,228 of the shares will vest each month starting on January 18, 2007.
[F8]The option vests as to 1/31th of the shares each month beginning on January 1, 2007.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

EPIX Pharmaceuticals, Inc.

CIK 0001027702

→

Entity typeoperating

Related Parties

filerCIK 0001027702

Filing Metadata

Form type: 4
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 5:34 PM ET
Size: 31.1 KB

View on SEC.gov